Advertisement
Advertisement

ELAN

ELAN logo

Elanco Animal Health Incorporated Common Stock

23.96
USD
Sponsored
+0.78
+3.36%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

24.39

+0.43
+1.79%

ELAN Earnings Reports

Positive Surprise Ratio

ELAN beat 26 of 31 last estimates.

84%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.34B
/
$0.27
Implied change from Q1 26 (Revenue/ EPS)
-2.35%
/
-32.50%
Implied change from Q2 25 (Revenue/ EPS)
+7.88%
/
+3.85%

Elanco Animal Health Incorporated Common Stock earnings per share and revenue

On May 06, 2026, ELAN reported earnings of 0.40 USD per share (EPS) for Q1 26, beating the estimate of 0.35 USD, resulting in a 13.38% surprise. Revenue reached 1.37 billion, compared to an expected 1.31 billion, with a 4.39% difference. The market reacted with a +13.88% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 13 analysts forecast an EPS of 0.27 USD, with revenue projected to reach 1.34 billion USD, implying an decrease of -32.50% EPS, and decrease of -2.35% in Revenue from the last quarter.
FAQ
For Q1 2026, Elanco Animal Health Incorporated Common Stock reported EPS of $0.40, beating estimates by 13.38%, and revenue of $1.37B, 4.39% above expectations.
The stock price moved up 13.88%, changed from $22.99 before the earnings release to $26.18 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 13 analysts, Elanco Animal Health Incorporated Common Stock is expected to report EPS of $0.27 and revenue of $1.34B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement